Julia Seay1, Atticus Ranck2, Roy Weiss1, Christopher Salgado3, Lydia Fein4, Erin Kobetz1. 1. 1 Department of Medicine, Miller School of Medicine, University of Miami , Miami, Florida. 2. 2 Sunshine Social Services, Inc. , Fort Lauderdale, Florida. 3. 3 Department of Surgery, Miller School of Medicine, University of Miami , Miami, Florida. 4. 4 Department of Obstetrics and Gynecology, Miller School of Medicine, University of Miami , Miami, Florida.
Abstract
PURPOSE: Transgender men are less likely than cisgender women to receive cervical cancer screening. The purpose of the current study was to understand experiences with and preferences for cervical cancer screening among transgender men. METHODS: Ninety-one transgender men ages 21-63 completed the survey. The survey evaluated experiences with and preferences for screening, including opinions regarding human papillomavirus (HPV) self-sampling as a primary cervical cancer screening. RESULTS: Half (50.5%) of participants did not have Pap smear screening within the past 3 years. The majority (57.1%) of participants preferred HPV self-sampling over provider-collected Pap smear screening. Participants who reported discrimination were more likely to prefer HPV self-sampling (odds ratio = 3.29, 95% confidence interval 1.38-7.84, P = 0.007). CONCLUSION: Primary HPV testing via HPV self-sampling may improve cervical cancer screening uptake among transgender men. Future work should pilot this innovative cervical cancer screening method within this population.
PURPOSE: Transgender men are less likely than cisgender women to receive cervical cancer screening. The purpose of the current study was to understand experiences with and preferences for cervical cancer screening among transgender men. METHODS: Ninety-one transgender men ages 21-63 completed the survey. The survey evaluated experiences with and preferences for screening, including opinions regarding human papillomavirus (HPV) self-sampling as a primary cervical cancer screening. RESULTS: Half (50.5%) of participants did not have Pap smear screening within the past 3 years. The majority (57.1%) of participants preferred HPV self-sampling over provider-collected Pap smear screening. Participants who reported discrimination were more likely to prefer HPV self-sampling (odds ratio = 3.29, 95% confidence interval 1.38-7.84, P = 0.007). CONCLUSION: Primary HPV testing via HPV self-sampling may improve cervical cancer screening uptake among transgender men. Future work should pilot this innovative cervical cancer screening method within this population.
Entities:
Keywords:
HPV; cervical cancer; screening; transgender men
Authors: Caitlin B Biddell; Meghan C O'Leary; Stephanie B Wheeler; Lisa P Spees Journal: Cancer Epidemiol Biomarkers Prev Date: 2020-05-26 Impact factor: 4.254
Authors: Matthew B Schabath; Catherine A Blackburn; Megan E Sutter; Peter A Kanetsky; Susan T Vadaparampil; Vani N Simmons; Julian A Sanchez; Steven K Sutton; Gwendolyn P Quinn Journal: J Clin Oncol Date: 2019-01-16 Impact factor: 44.544
Authors: Alison M Berner; Dean J Connolly; Imogen Pinnell; Aedan Wolton; Adriana MacNaughton; Chloe Challen; Kate Nambiar; Jacob Bayliss; James Barrett; Christina Richards Journal: Br J Gen Pract Date: 2021-07-29 Impact factor: 6.302
Authors: Sari L Reisner; Madeline B Deutsch; Sarah M Peitzmeier; Jaclyn M White Hughto; Timothy P Cavanaugh; Dana J Pardee; Sarah A McLean; Lori A Panther; Marcy Gelman; Matthew J Mimiaga; Jennifer E Potter Journal: PLoS One Date: 2018-03-14 Impact factor: 3.240
Authors: Madina Agénor; Gabriel R Murchison; Jesse Najarro; Alyssa Grimshaw; Alischer A Cottrill; Elizabeth Janiak; Allegra R Gordon; Brittany M Charlton Journal: Sex Reprod Health Matters Date: 2021-12